INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

79,760 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
WI
Winkles IsabelleChief Financial Officer
BRZEBraze, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
8,274 sh
Apr 6, 2026Apr 8, 2026
Page 1236 of 1994
← PrevNext →
traded Apr 6, 2026
+2d
SEC Form 4

Evidence

9
PF
Paolini John F.CHIEF MEDICAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,497 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

8
BJ
Balance Austin JChief Product Officer
GRNDGrindr Inc.
Tax withholding
F$163K
13.4K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
TR
Taylor Ben RChief Financial Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Tax withholding
F$149K
48.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$180K
3,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

8
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Tax withholding
F$122K
10.1K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
BT
Beer Michael ThomasChief Financial Officer
NRGVEnergy Vault Holdings, Inc.
Option exercise
M$59K
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

7
CA
Cannestra AnthonyDirector
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

6
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$38K
900 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$198K
3,900 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

6
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$124K
40.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

6
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$119K
10.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

6
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$57K
5,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,694 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
TE
Tessari EbenCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,726 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Grant or award
A—
450 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

5
TE
Tessari EbenCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Tax withholding
F$41K
846 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$454K
16.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

5
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$260K
13.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

4
AJ
Allison JonathanChief Administrative Officer
ROOTRoot, Inc.
Open-market sale · 10b5-1 plan
SELL$76K
1,706 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 8, 2026Apr 8, 2026
traded Apr 8, 2026
+0dSEC Form 4

Evidence

4
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$93K
5,228 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

3
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
13.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

3
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,477 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

3
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
16.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
900 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

2
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M$78K
3,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M—
1,273 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
100.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
FA
Feuardent Moreira AndreasChief Innovation Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$100
10.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
CA
Cannestra AnthonyDirector
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M$28K
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
27.1K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Derivative conversion · 10b5-1 plan
C—
52.4K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
6,250 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
6,250 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M$102
1,273 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence